Lockheed Martin Investment Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-16,474
Closed -$223K 172
2021
Q4
$223K Buy
+16,474
New +$233K 0.01% 173

Other funds holding SBRA

Lockheed Martin Investment Management's SBRA Position: Q1 2022 in Review

Lockheed Martin Investment Management sold out of Sabra Healthcare REIT (SBRA) in Q1 2022, closing a stake of 16,474 shares — an estimated $223K sold.

Lockheed Martin Investment Management first reported a position in SBRA in Q4 2021 and held it in 1 quarter. The position peaked at $223K in Q4 2021. 326 funds tracked by Wall St. Rank hold SBRA as of Q1 2022.

  • Lockheed Martin Investment Management reported no remaining Sabra Healthcare REIT position as of Q1 2022 after selling out during the quarter.
  • Lockheed Martin Investment Management sold 16,474 Sabra Healthcare REIT shares in Q1 2022, an estimated $223K.
  • Lockheed Martin Investment Management first reported a position in Sabra Healthcare REIT in Q4 2021 and held it in 1 quarter.
  • Lockheed Martin Investment Management's Sabra Healthcare REIT position peaked at $223K in Q4 2021.
  • 326 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2022.

Based on Lockheed Martin Investment Management's 13F filing for Q1 2022, filed 12 May 2022.